NCT04030507
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Inflammatory Breast Cancer
Explore clinical trials studying Inflammatory Breast Cancer. Study availability and eligibility vary by location and protocol.
23 public trials
2 recruiting studies
Inflammatory Breast Cancer trial results
Recruiting
Refining Local-Regional Therapy for IBC
NCT04636710
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06131632
- Conditions
- Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +5 more
- Locations
-
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
Active, not recruiting
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT02623972
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
NCT01525966
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
Active, not recruiting
Onvansertib + Paclitaxel In TNBC
NCT05383196
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
NCT03515798
- Conditions
- Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +5 more
- Locations
-
- Clinique de L'Europe Amiens, France
- Institut Sainte Catherine Avignon, France
- Institut BERGONIE Bordeaux, France
- CENTRE Francois Baclesse Caen, France
Active, not recruiting
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Department of Thyroid and Breast Gland Surgery,Shenzhen Longgang Central Hospital Shenzhen, Guangdong, China
- HanDan Central Hospital Handan, Hebei, China
- The First Affiliated Hospital of University of South China Hengyang, Hunan, China
- Department of Thyroid and Breast Surgery, The Affiliated Hospital of Inner Mongolia Medical Collage Hohhot, Inner Mongolia, China
- Conditions
- Behavior, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Centro de Investigaciones Médicas y Desarrollo LC S.R.L Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina
- Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
- University Clinical Center of the Republic of Srpska Banja Luka, Bosnia and Herzegovina
- Cantonal Hospital Zenica Zenica, Bosnia and Herzegovina
NCT01417286
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +22 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Huntsman Cancer Hospital Salt Lake City, Utah, United States